Company Quick10K Filing
Nate's Food
10-K 2018-05-31 Filed 2019-04-19
10-Q 2018-02-28 Filed 2018-07-06
10-Q 2017-11-30 Filed 2018-05-24
10-Q 2017-08-31 Filed 2018-02-21
10-K 2017-05-31 Filed 2017-12-22
10-Q 2017-02-28 Filed 2017-05-17
10-Q 2016-11-30 Filed 2017-01-23
10-Q 2016-08-31 Filed 2016-10-24
10-K 2016-05-31 Filed 2016-10-06
10-Q 2016-02-29 Filed 2016-06-28
10-Q 2015-11-30 Filed 2016-01-21
10-Q 2015-08-31 Filed 2015-10-20
10-K 2015-05-31 Filed 2015-09-21
10-Q 2015-02-28 Filed 2015-04-14
10-Q 2014-11-30 Filed 2015-01-20
10-Q 2014-08-31 Filed 2014-11-10
10-Q 2010-09-30 Filed 2010-11-18
10-K 2010-06-30 Filed 2010-10-13
10-Q 2010-03-31 Filed 2010-05-14
10-Q 2009-12-31 Filed 2010-02-11
8-K 2018-01-08 Accountant, Exhibits
8-K 2017-12-21 Other Events
8-K 2017-12-21 Other Events

Nate's Food Financials

NHMD Metrics, Comps, Filings

Quarterly | Annual

Business

Our financial statements are stated in United States Dollars (US$) and are prepared in accordance with United States Generally Accepted Accounting Principles.

In this annual report, unless otherwise specified, all dollar amounts are expressed in United States dollars and all references to "common shares" refer to the common shares in our capital stock.

As used in this current report and unless otherwise indicated, the terms "we", "us" and "our" mean Nate's Food Co., unless otherwise indicated.


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Cantabio Pharmaceuticals (CTBO) 0 0.9 -474% 326 2,215 0 0 -1,543 -331 -283
Natcore Technology (NXT)
Nutra Pharma (NPHC) 0 71% -0.2 -2,939% 252 5,614 106 75 -7,398 -6,591 1,498
Premier Biomedical (BIEI) 0 58% -0.3 -183% 186 2,304 13 8 -340 -238 75
Nate's Food (NHMD) 0 92% -0.1 -6,857% 7 825 3 3 -481 -455 30
Amplitude Healthcare (AMHCU)
Galileo Acquisition (GLEO)
GH Capital (GHHC) 0 66% -0.0 -2,680% 89 331 211 139 -2,374 -2,374 59
Life Clips (LCLP) 0 135% -0.7 -21,823% 16 9,270 -86 -116 -3,494 -3,182 2,355
Sunshine Biopharma (SBFM) 0 30% 0.1 -864% 146 889 130 38 -1,264 -1,160 -82
New You (NWYU)
VNUE (VNUE) 0 0% -2.0 -621% 168 3,666 200 0 -1,042 -634 1,242
Electromedical Technologies (ELCQ)
DigitalTown (DGTW) 0 12,618% 0.0 -16,557% 34 2,761 -2 -220 -5,706 -5,268 -34
Angiosoma (SOAN) 0 64% -0.2 -475% 142 828 0 0 -675 -315 66
XsunX (XSNX) 0 47% 0.1 1,089% 215 2,451 1,609 753 2,344 2,417 194
Pacific Ventures (PACV) 0 25% -3.8 -65% 1,799 5,073 3,514 883 -1,171 -615 2,318
Anchiano Therapeutics (ANCN)
X Rail Entertainment (XREE) 0 -0.1 -1,441,401% 0 3,429 0 0 -5,261 -5,732 345
GIFA (FRFS) 0 63% -0.9 43% 80 362 98 62 34 34 -30

Balance Sheet ($'000)2014-08-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-31
Cash24010184731229312017
Accounts Receivable
Inventory5
PP&E3743953953853753660
Assets24018521947844341338740536912017
Accounts Payable33
Long-Term Debt102420020020018715436237373737
Liabilities771241744166151,0291,2582,851733868765526613641709825
Stockholders' Equity-74-84-172-331-396-551-815-2,438-345-464-397-525-612-641-708-818
Income Statement ($'000)2014-08-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-31
Revenue112218003810211
Cost of Revenue00013507050-0000
Gross Profit112830-73310211
R&D67142402-2200020000
SG&A458536029677318920397396198442115
Tax000000000
Net Income-71-5991,780-2,291-125-329-709-1,7651,5111,80917-599-293-29-159
Cash Flow ($'000)2014-08-312014-11-302015-02-282015-05-312015-08-312015-11-302016-02-292016-05-312016-08-312016-11-302017-02-282017-05-312017-08-312017-11-302018-02-282018-05-31
Cash Operating-3-5-38-26-11-53-36-22-144-45-26-31-2-6
Cash Investing-99-12-2100000000
Cash Financing543-011012813201457200017